Potential efficacy of Lactobacillus casei IBRC_M10711 on expression and activity of insulin degrading enzyme but not insulin degradation

In Vitro Cell Dev Biol Anim. 2017 Jan;53(1):12-19. doi: 10.1007/s11626-016-0083-4. Epub 2016 Aug 29.

Abstract

Type 2 diabetes (T2D) is a condition with insufficient insulin production or in the setting of insulin resistance with many origins including intestinal microbiota-related molecular mechanism. Insulin-degrading enzyme (IDE) is responsible for insulin breakdown in various tissues and is known as a potential drug target for T2D. Here, we assessed the effects of cell-free supernatant (CFS) and UV-killed Lactobacillus casei IBRC_M10711 on IDE expression, IDE activity, and insulin degradation in Caco-2 cell line. It was found that CFS and UV-killed L. casei IBRC_M10711 led to lower expression of IDE. UV-killed L. casei IBRC_M10711 significantly inhibited IDE activity but CFS did not. Insulin degradation was affected with none of them. In conclusion, L. casei IBRC_M10711 is effective on IDE expression and its activity, but not on insulin degradation. Future studies are recommended to explore the effect of this probiotic on other substrates of IDE.

Keywords: Cell-free supernatant; Insulin degradation; Insulin-degrading enzyme; Lactobacillus casei IBRC_M10711; UV-killed.

MeSH terms

  • Caco-2 Cells
  • Cell Proliferation
  • Cell-Free System
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Insulin / metabolism*
  • Insulysin / metabolism*
  • Lacticaseibacillus casei / metabolism*
  • Lacticaseibacillus casei / radiation effects
  • Microbial Viability / radiation effects
  • Proteolysis*
  • Ultraviolet Rays

Substances

  • Insulin
  • Insulysin